By 2031, regulators approve adaptive prostheses as bounded design systems, allowing clinical agents to reshape each device as its wearer grows or their gait changes.
A prosthesis is no longer a finished object replaced every few years. It becomes a continuously revised system whose geometry adapts within clinician-approved constraints. Device makers earn revenue from validated design rules, while local clinics manufacture updated parts near the wearer and preserve the option of restoring an earlier shape.
At 6:25 a.m. in a Busan apartment, twelve-year-old Ji-an clips an ankle component printed overnight into her prosthesis. Her clinician has already approved the agent's proposed change, prompted by a limp recorded on her walk home the previous day. Before leaving for school, Ji-an tests the new part in the stairwell.
A vendor could narrow the permitted design space, extract intimate movement data, or disable older components through an update. The optimistic outcome depends on independent records, interchangeable parts, offline controls, and a permanent right to manual fitting.